HDL Cholesterol Efflux Capacity is Impaired in Severe Short-Term Hypothyroidism Despite Increased HDL Cholesterol
- 1 September 2020
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 105 (9), e3355-e3362
- https://doi.org/10.1210/clinem/dgaa411
Abstract
Context Severe hypothyroidism has profound effects on lipoprotein metabolism including high-density lipoprotein (HDL) cholesterol elevations but effects on HDL function metrics are unknown. Objective To determine the impact of severe short-term hypothyroidism on HDL particle characteristics, HDL cholesterol efflux capacity (CEC), and HDL antioxidative capacity. Design Observational study with variables measured during severe short-term hypothyroidism (median TSH 81 mU/L) and after 20 weeks of thyroid hormone supplementation (median TSH 0.03 mU/L) (Netherlands Trial Registry ID 7228). Setting University hospital setting in The Netherlands. Patients Seventeen patients who had undergone a total thyroidectomy for differentiated thyroid carcinoma. Main outcome measures HDL particle characteristics (nuclear magnetic resonance spectrometry), CEC (human THP-1-derived macrophage foam cells and apolipoprotein B-depleted plasma), and HDL anti-oxidative capacity (inhibition of low-density lipoprotein oxidation). Results During hypothyroidism plasma total cholesterol, HDL cholesterol and apolipoprotein A-I were increased (P ≤ 0.001). HDL particle concentration was unchanged, but there was a shift in HDL subclasses toward larger HDL particles (P < 0.001). CEC was decreased (P = 0.035), also when corrected for HDL cholesterol (P < 0.001) or HDL particle concentration (P = 0.011). HDL antioxidative capacity did not change. Conclusion During severe short-term hypothyroidism CEC, an important antiatherogenic metric of HDL function, is impaired. HDL cholesterol and larger HDL particles are increased but HDL particle concentration is unchanged. Combined, these findings suggest that HDL quality and quantity are not improved, reflecting dysfunctional HDL in hypothyroidism.Keywords
Funding Information
- National Institutes of Health
- Netherlands Organization for Scientific Research (917-56-358)
This publication has 46 references indexed in Scilit:
- High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin TherapyJournal of the American College of Cardiology, 2013
- Cholesterol Efflux and AtheroprotectionJournal of the American College of Cardiology, 2012
- The Effect of Thyroid Disorders on Lipid Levels and MetabolismMedical Clinics of North America, 2012
- Thyroid hormone enhances the ability of serum to accept cellular cholesterol via the ABCA1 transporterAtherosclerosis, 2011
- Increased LCAT activity and hyperglycaemia decrease the antioxidative functionality of HDLEuropean Journal of Clinical Investigation, 2011
- Apolipoprotein B/A-I and total cholesterol/high-density lipoprotein cholesterol ratios both predict cardiovascular events in the general population independently of nonlipid risk factors, albuminuria and C-reactive proteinJournal of Internal Medicine, 2010
- Major Lipids, Apolipoproteins, and Risk of Vascular DiseaseJAMA, 2009
- The activity of cholesteryl ester transfer protein is decreased in hypothyroidism: a possible contribution to alterations in high‐density lipoproteinsEuropean Journal of Clinical Investigation, 1990
- Changes in the distribution and composition of high-density lipoproteins in primary hypothyroidismMetabolism, 1985
- Serum lipids and apolipoproteins A-I, A-II and B in primary hypothyroidism before and during treatmentEuropean Journal of Clinical Investigation, 1984